Literature DB >> 16170605

A 9-year study comparing risk factors and the outcome of paediatric and adults with nosocomial candidaemia.

A C Pasqualotto1, W L Nedel, T S Machado, L C Severo.   

Abstract

Although there are numerous studies of candidaemia in adults, data on paediatrics are still limited. The aim of this study was to compare risk factors, aetiology, therapy, and the outcome of nosocomial candidaemia among paediatric and adult patients in a large Brazilian tertiary hospital (1995-2003). During this period, 78 paediatrics and 113 adults were studied. Species other than Candida albicans caused 78.2% of episodes of candidaemia in paediatrics. Compared to adults, paediatrics received more frequently broad-spectrum antibiotics, vasopressors, blood transfusions, arterial catheter, chest tube, cardiothoracic surgery, mechanical ventilation, and parenteral nutrition. Candidaemia caused by Candida parapsilosis was more common in paediatrics, as was the isolation of Candida spp. from catheters. Amphotericin B treatment was more common in paediatrics. Mortality rate was higher in adults than in paediatrics with nosocomial candidaemia. We reinforce the necessity of continuous epidemiologic surveillance to follow the dynamics of candidaemia.

Entities:  

Mesh:

Year:  2005        PMID: 16170605     DOI: 10.1007/s11046-005-3452-1

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  24 in total

1.  Mortality associated with systemic candidiasis in children.

Authors:  A Pacheco-Ríos; C Avila-Figueroa; D Nobigrot-Kleinman; J I Santos
Journal:  Arch Med Res       Date:  1997       Impact factor: 2.235

2.  Vertical and horizontal transmission of unique Candida species to premature newborns.

Authors:  L A Waggoner-Fountain; M W Walker; R J Hollis; M A Pfaller; J E Ferguson; R P Wenzel; L G Donowitz
Journal:  Clin Infect Dis       Date:  1996-05       Impact factor: 9.079

3.  Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000.

Authors:  M A Pfaller; D J Diekema; R N Jones; S A Messer; R J Hollis
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

4.  Emergence of Candida parapsilosis as the predominant species causing candidemia in children.

Authors:  I Levy; L G Rubin; S Vasishtha; V Tucci; S K Sood
Journal:  Clin Infect Dis       Date:  1998-05       Impact factor: 9.079

5.  Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group.

Authors:  L Saiman; E Ludington; M Pfaller; S Rangel-Frausto; R T Wiblin; J Dawson; H M Blumberg; J E Patterson; M Rinaldi; J E Edwards; R P Wenzel; W Jarvis
Journal:  Pediatr Infect Dis J       Date:  2000-04       Impact factor: 2.129

Review 6.  Candidemia in a pediatric population.

Authors:  J K Stamos; A H Rowley
Journal:  Clin Infect Dis       Date:  1995-03       Impact factor: 9.079

7.  A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

Authors:  Peter G Pappas; John H Rex; Jeannette Lee; Richard J Hamill; Robert A Larsen; William Powderly; Carol A Kauffman; Newton Hyslop; Julie E Mangino; Stanley Chapman; Harold W Horowitz; John E Edwards; William E Dismukes
Journal:  Clin Infect Dis       Date:  2003-08-14       Impact factor: 9.079

Review 8.  Candida infections in the neonate.

Authors:  Rachel L Chapman
Journal:  Curr Opin Pediatr       Date:  2003-02       Impact factor: 2.856

9.  Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases.

Authors:  E H Kossoff; E S Buescher; M G Karlowicz
Journal:  Pediatr Infect Dis J       Date:  1998-06       Impact factor: 2.129

Review 10.  Amphotericin B nephrotoxicity in children.

Authors:  Ran D Goldman; Gideon Koren
Journal:  J Pediatr Hematol Oncol       Date:  2004-07       Impact factor: 1.289

View more
  9 in total

1.  Neonatal intensive care unit candidemia: epidemiology, risk factors, outcome, and critical review of published case series.

Authors:  A Spiliopoulou; G Dimitriou; E Jelastopulu; I Giannakopoulos; E D Anastassiou; Myrto Christofidou
Journal:  Mycopathologia       Date:  2011-11-11       Impact factor: 2.574

2.  Comparison of nosocomial candidemia of pediatric and adult cases in 2-years period at a Turkish university hospital.

Authors:  Asuman Birinci; Yeliz Tanriverdi Cayci; Kemal Bilgin; Murat Gunaydin; Cagatay Acuner; Saban Esen
Journal:  Eurasian J Med       Date:  2011-08

3.  A prospective cohort study evaluating the prognostic impact of clinical characteristics and comorbid conditions of hospitalized adult and pediatric cancer patients with candidemia.

Authors:  E Velasco; R Bigni
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-12       Impact factor: 3.267

4.  Transcriptional response of Candida parapsilosis following exposure to farnesol.

Authors:  Tristan Rossignol; Mary E Logue; Kieran Reynolds; Muriel Grenon; Noel F Lowndes; Geraldine Butler
Journal:  Antimicrob Agents Chemother       Date:  2007-07       Impact factor: 5.191

5.  Development of a gene knockout system in Candida parapsilosis reveals a conserved role for BCR1 in biofilm formation.

Authors:  Chen Ding; Geraldine Butler
Journal:  Eukaryot Cell       Date:  2007-06-22

6.  Candidaemia and cancer: patients are not all the same.

Authors:  Alessandro Comarú Pasqualotto; Daniela Dornelles Rosa; Lidia Rosi Medeiros; Luiz Carlos Severo
Journal:  BMC Infect Dis       Date:  2006-03-16       Impact factor: 3.090

7.  Susceptibility of Candida spp. isolated from blood cultures as evaluated using the M27-A3 and new M27-S4 approved breakpoints.

Authors:  Edileusa Rosa dos Santos; Camila F Dal Forno; Mari Glei Hernandez; Thaís Felli Kubiça; Tarcieli P Venturini; Francieli Chassot; Janio M Santurio; Sydney Hartz Alves
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Nov-Dec       Impact factor: 1.846

8.  Yeast colonization and drug susceptibility pattern in the pediatric patients with neutropenia.

Authors:  Pedram Haddadi; Soheila Zareifar; Parisa Badiee; Abdolvahab Alborzi; Maral Mokhtari; Kamiar Zomorodian; Keyvan Pakshir; Hadis Jafarian
Journal:  Jundishapur J Microbiol       Date:  2014-09-01       Impact factor: 0.747

9.  Antifungal susceptibility patterns of colonized Candida species isolates from immunocompromised pediatric patients in five university hospitals.

Authors:  Parisa Badiee; Maral Choopanizadeh; Abdolkarim Ghadimi Moghadam; Ali Hossaini Nasab; Hadis Jafarian; Ahmad Shamsizadeh; Jafar Soltani
Journal:  Iran J Microbiol       Date:  2017-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.